Levine Leichtman Capital Partners Get Shipley Do-Nuts
Shipley Do-Nuts, a US-based donut and colach brand, has been acquired by Peak Rock Capital’s private equity company Levine Leichtman Capital Partners (LLCP).
Details of the transaction’s financial details have not been revealed. However, the deal reported that it could value the brand at $400 million. Bloombergquote source.
The executive team of Shipley Do-Nuts, led by CEO Flynn Dekker, continues to operate its Houston headquarters.
Matthew Frankel, LLCP managing partner, said:
“Together, we see a great opportunity to build on this foundation by expanding the number of units further, gaining significant gaps and driving strong sales growth for the same store.”
In January 2021, Peakrock Capital acquired a majority stake in Shipley from its original ownership family.
Shipley operates over 375 locations in 14 US states and offers over 60 types of donuts and colaches. And coffee.
The Shipley acquisition represents the fourth platform investment in LLCP’s Fund VII. LLCP’s portfolio includes investments in brands such as Tropical Smoothie Cafe, Nothing Bundt Cakes, and Hand & Stone.
Shipley is now LLCP’s 18th franchise investment, bringing a total of 32 brands across a range of industries.
Dekker said: “Shipley has grown faster than ever in history, and our partnership with LLCP offers an outstanding opportunity for Shipley to accelerate our growth and bring the world’s largest doughnuts to a wider audience.
“Their extensive expertise in franchise food brands is crucial to driving future growth and supporting franchisees, maintaining fresh quality and commitment to original recipes that make our brand an icon of today.”
LLCP legal advice was provided by Kirkland & Ellis and DLA Piper, and Shipley received guidance from North Point and JP Morgan.
March 2025, Shipley 30 unit development agreement signed To expand its national footprint.
“Levine Leichtman Capital Partners Acquire Shipley Do-Nuts” was originally created and published Verdict Food Servicea brand owned by GlobalData.
The information on this site is contained in good faith for general information purposes only. It is not intended to be the advice you should resort to, and we will not give any representations, warranties or warranties, whether express or implied regarding its accuracy or completeness. You should seek expert or expert advice before taking or refraining from taking any medication based on the content on our site.